3.19.3.a.u2 html 108 234 1 false 34 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://cnspharma.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets (Unaudited) Sheet http://cnspharma.com/role/BalanceSheets Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) Sheet http://cnspharma.com/role/BalanceSheetsParenthetical Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://cnspharma.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Stockholders' Equity (Deficit) (Unaudited) Sheet http://cnspharma.com/role/StatementsOfStockholdersEquityDeficit Statements of Stockholders' Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Statements of Cash Flows (Unaudited) Sheet http://cnspharma.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - 1. Nature of Business Sheet http://cnspharma.com/role/NatureOfBusiness 1. Nature of Business Notes 7 false false R8.htm 00000008 - Disclosure - 2. Summary of Significant Accounting Policies Sheet http://cnspharma.com/role/SummaryOfSignificantAccountingPolicies 2. Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - 3. Notes Payable Notes http://cnspharma.com/role/NotesPayable 3. Notes Payable Notes 9 false false R10.htm 00000010 - Disclosure - 4. SAFE Agreements Sheet http://cnspharma.com/role/SafeAgreements 4. SAFE Agreements Notes 10 false false R11.htm 00000011 - Disclosure - 5. Equity Sheet http://cnspharma.com/role/Equity 5. Equity Notes 11 false false R12.htm 00000012 - Disclosure - 6. Commitments and Contingencies Sheet http://cnspharma.com/role/CommitmentsAndContingencies 6. Commitments and Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - 7. Subsequent Events Sheet http://cnspharma.com/role/SubsequentEvents 7. Subsequent Events Notes 13 false false R14.htm 00000014 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) Sheet http://cnspharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. Summary of Significant Accounting Policies (Policies) Policies http://cnspharma.com/role/SummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - 2. Summary of Significant Accounting Policies (Tables) Sheet http://cnspharma.com/role/SummaryOfSignificantAccountingPoliciesTables 2. Summary of Significant Accounting Policies (Tables) Tables http://cnspharma.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - 5. Equity (Tables) Sheet http://cnspharma.com/role/EquityTables 5. Equity (Tables) Tables http://cnspharma.com/role/Equity 16 false false R17.htm 00000017 - Disclosure - 2. Summary of Significant Accounting Policies (Details - Restricted Cash) Sheet http://cnspharma.com/role/SummaryOfSignificantAccountingPoliciesDetails-RestrictedCash 2. Summary of Significant Accounting Policies (Details - Restricted Cash) Details http://cnspharma.com/role/SummaryOfSignificantAccountingPoliciesTables 17 false false R18.htm 00000018 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative) Sheet http://cnspharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative 2. Summary of Significant Accounting Policies (Details Narrative) Details http://cnspharma.com/role/SummaryOfSignificantAccountingPoliciesTables 18 false false R19.htm 00000019 - Disclosure - 3. Notes Payable (Details Narrative) Notes http://cnspharma.com/role/NotesPayableDetailsNarrative 3. Notes Payable (Details Narrative) Details http://cnspharma.com/role/NotesPayable 19 false false R20.htm 00000020 - Disclosure - 4. SAFE Agreements (Details Narrative) Sheet http://cnspharma.com/role/SafeAgreementsDetailsNarrative 4. SAFE Agreements (Details Narrative) Details http://cnspharma.com/role/SafeAgreements 20 false false R21.htm 00000021 - Disclosure - 5. Equity (Details - Option Activity) Sheet http://cnspharma.com/role/EquityDetails-OptionActivity 5. Equity (Details - Option Activity) Details http://cnspharma.com/role/EquityTables 21 false false R22.htm 00000022 - Disclosure - 5. Equity (Details - Options by exercise price) Sheet http://cnspharma.com/role/EquityDetails-OptionsByExercisePrice 5. Equity (Details - Options by exercise price) Details http://cnspharma.com/role/EquityTables 22 false false R23.htm 00000023 - Disclosure - 5. Equity (Details - Warrant Activity) Sheet http://cnspharma.com/role/EquityDetails-WarrantActivity 5. Equity (Details - Warrant Activity) Details http://cnspharma.com/role/EquityTables 23 false false R24.htm 00000024 - Disclosure - 5. Equity (Details - Warrants by exercise price) Sheet http://cnspharma.com/role/EquityDetails-WarrantsByExercisePrice 5. Equity (Details - Warrants by exercise price) Details http://cnspharma.com/role/EquityTables 24 false false R25.htm 00000025 - Disclosure - 5. Equity (Details Narrative) Sheet http://cnspharma.com/role/EquityDetailsNarrative 5. Equity (Details Narrative) Details http://cnspharma.com/role/EquityTables 25 false false R26.htm 00000026 - Disclosure - 6. Commitments and Contingencies (Details Narrative) Sheet http://cnspharma.com/role/CommitmentsAndContingenciesDetailsNarrative 6. Commitments and Contingencies (Details Narrative) Details http://cnspharma.com/role/CommitmentsAndContingencies 26 false false R27.htm 00000027 - Disclosure - 7. Subsequent Events (Details Narrative) Sheet http://cnspharma.com/role/SubsequentEventsDetailsNarrative 7. Subsequent Events (Details Narrative) Details http://cnspharma.com/role/SubsequentEvents 27 false false All Reports Book All Reports cnsp-20190930.xml cnsp-20190930.xsd cnsp-20190930_cal.xml cnsp-20190930_def.xml cnsp-20190930_lab.xml cnsp-20190930_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 true true